MN
Congress trade
Rep. Marie Newman (D-IL) sold $15K-$50K of Moderna, Inc. (MRNA) stock
Marie Newman, U.S. Representative (D-IL), disclosed a sale of Moderna, Inc. (MRNA) stock worth $15K-$50K in a STOCK Act filing on Feb 13, 2021.
The trade happened on Jan 8, 2021, 36 days before it was made public.
MRNA has moved +68.5% since the trade date, from $112.75 to $190.01 (Oct 2, 2026 close).
- Traded
- Jan 8, 2021
- Disclosed
- Feb 13, 2021
- Filing delay
- 36 days
- Price since
- +68.5%
- Source
- STOCK Act disclosure
Other trades in this disclosure (57)
- SellNFLX$100K-$250KFeb 13, 2021
- BuyNFLX$50K-$100KFeb 13, 2021
- BuyBA$15K-$50KFeb 13, 2021
- SellBBY$15K-$50KFeb 13, 2021
- SellCRM$15K-$50KFeb 13, 2021
- SellDOCU$15K-$50KFeb 13, 2021
- BuyDOCU$15K-$50KFeb 13, 2021
- SellFDX$15K-$50KFeb 13, 2021
- BuyMCD$15K-$50KFeb 13, 2021
- SellMCD$15K-$50KFeb 13, 2021
- BuyMCD$15K-$50KFeb 13, 2021
- SellMCD$15K-$50KFeb 13, 2021
- BuyMSFT$15K-$50KFeb 13, 2021
- SellMSFT$15K-$50KFeb 13, 2021
- SellW$15K-$50KFeb 13, 2021
- SellW$15K-$50KFeb 13, 2021
- SellZM$15K-$50KFeb 13, 2021
- BuyAAPL$1K-$15KFeb 13, 2021
- SellAAPL$1K-$15KFeb 13, 2021
- BuyCHWY$1K-$15KFeb 13, 2021
More MRNA insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.